Inactive Instrument
Pandion Therapeutics, Inc. Stock
Stocks
PAND
US6983401067
Biotechnology & Medical Research
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 58 | - |
| Chief Tech/Sci/R&D Officer | - | 01/08/2020 | |
Edward Freedman
COO | Chief Operating Officer | 57 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/04/21 | New Leaf Venture Partners LLC
| Tender | Company | 2,827,883 | 9.5810% | |
| 01/04/21 | Tender | Director | 91,738 | 0.3108% | ||
| 01/04/21 | Tender | Vice President, Finance | 72,625 | 0.2461% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | +0.13% | - | - | 1.7B | |
| -0.21% | +0.18% | +57.19% | +108.17% | 54.92B | |
| -0.34% | +3.51% | +45.55% | +40.16% | 44.31B | |
| +0.29% | +6.20% | -14.80% | -19.65% | 22.96B | |
| -0.40% | +3.49% | -1.29% | +387.06% | 21.12B | |
| -2.91% | +0.27% | +13.28% | -36.73% | 16.31B | |
| -1.25% | -2.24% | +6.78% | -41.18% | 15.19B | |
| -0.24% | +2.44% | +27.43% | +177.49% | 13.32B | |
| +1.48% | +9.81% | +19.29% | - | 12.48B | |
| +0.32% | +2.81% | +96.37% | +213.49% | 11.21B | |
| Average | -0.32% | +2.75% | +27.76% | +103.60% | 23.54B | |
| Weighted average by Cap. | -0.38% | +2.86% | +32.10% | +95.20% |
Employees
56
